For approximately 100,000 people per year with symptoms of suspected CRC, we predict it might save > 4500 colonoscopies with no evidence that more cancers would be missed if we used our model compared to using FIT f‐Hb ≥ 10 μg/g. Here, GSTM1 is linked to colorectal carcinoma.